Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling intervention effects after cancer relapses.

Juan R González1, Edsel A Peña, Elizabeth H Slate

  • 1Cancer Prevention and Control Unit, Catalan Institute of Oncology, Avda. Gran via s/n, km. 2.7, Hospitalet de Llobregat 08907, Spain. juanramon.gonzalez@crg.es

Statistics in Medicine
|December 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of Second Metabolic Threshold and Maximal Lactate Steady State using Sweat-Inferred Blood Lactate in Active Individuals and Athletes.

Medicine and science in sports and exercise·2026
Same author

Radiomic analysis of computed tomography scans in COPD patients relates to different clinical and biological features, and identifies different lung function trajectories during follow-up.

ERJ open research·2026
Same author

dsLassoCov: a federated Lasso approach incorporating covariate control.

Scientific reports·2026
Same author

Variable selection for explaining interindividual heterogeneity in longitudinal growth trajectories.

Psychological methods·2026
Same author

A Computational Framework for Simulating Patient-Specific TMJ Biomechanics Using a Combined Multibody Dynamics and Finite Element Approach.

Annals of biomedical engineering·2026
Same author

Analysis Methods for Diagnosing Rare Neurodevelopmental Diseases with Episignatures: A Systematic Review of the Literature.

Biomedicines·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study introduces a new model for analyzing repeated cancer relapses, allowing treatment effects to vary after each relapse. The model accounts for different patient responses to therapy, improving predictions for cancer recurrence.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Oncology

Background:

  • Modeling repeated cancer relapses is complex, especially when accounting for treatment effects.
  • Existing models often assume a constant intervention impact, which may not reflect clinical reality.
  • Understanding how interventions affect relapse dynamics is crucial for patient management.

Purpose of the Study:

  • To develop a flexible statistical model for recurrent cancer events that allows time-varying intervention effects.
  • To incorporate different therapeutic responses (complete remission, partial remission, null response) into the relapse model.
  • To analyze patient data for indolent lymphoma to demonstrate the model's utility.

Main Methods:

  • Adoption of the Peña and Hollander general model for recurrent events.

Related Experiment Videos

  • Introduction of an effective age process to represent intervention impact on the baseline hazard rate.
  • Development of a novel effective age function encoding three distinct therapeutic responses.
  • Inclusion of covariates, prior relapse history, and individual heterogeneity.

    • Main Results:

    • The proposed model successfully analyzed relapse times for 63 indolent lymphoma patients.
    • The model demonstrated the ability to capture varying intervention effects across multiple relapses.
    • Comparison with existing methods highlighted the advantages of the new approach in accounting for nuanced treatment impacts.

    Conclusions:

    • The developed model offers a more realistic framework for analyzing recurrent cancer events with time-dependent treatment effects.
    • It provides a valuable tool for understanding the complex interplay between interventions, patient characteristics, and cancer relapse patterns.
    • This approach can lead to improved prognostic models and personalized treatment strategies in oncology.